You can no longer update your profile information here in University Directory.
- By 31 May, please review and update your Discovery Profiles using the Te Waka Huia Rangahau | Research Outputs system.
- Use the Profile Review Checklist as a guide of the activities to complete as you review and enhance your profile.
- On 7 June, the University Directory will be fully decommissioned and will no longer be accessible or visible inside or outside of the University, Discovery Profiles will replace the externally facing elements of University Directory.
Dr Graeme John Finlay
MSc (Hons) PhD BTh
Honorary Academic
Dr
Graeme
John
Finlay
Dr Graeme John Finlay
https://unidirectory.auckland.ac.nz/profile/g-finlay
Honorary Academic
The University of Auckland: Molecular Medicine and Pathology
Teaching | Current
Course Director, MEDSCI 203, Mechanisms of Disease
Course Director, MEDSCI 101G, Environmental Threats to Human Health
Selected publications and creative works (Research Outputs)
As of 29 October 2020 there will be no automatic updating of 'selected publications and creative works' from Research Outputs. Please continue to keep your
Research Outputs profile up to date.
- Chen, Y. Y., Finlay, G. J., Kirker, J. A., Marshall, E. S., Richardson, E., & Baguley, B. C. (2011). In vivo and in vitro assessment of the action of SN 28049, a benzonaphthyridine derivative targeting topoisomerase II, on the murine Colon 38 carcinoma. INVESTIGATIONAL NEW DRUGS, 29 (6), 1504-1510. 10.1007/s10637-010-9509-0
Other University of Auckland co-authors: Bruce Baguley - Drummond, C. J., Finlay, G. J., Broome, L., Marshall, E. S., Richardson, E., & Baguley, B. C. (2010). Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide. Investigational New Drugs, 1-9.
Other University of Auckland co-authors: Bruce Baguley - Bridewell, D. J. A., Porter, A. C. G., Finlay, G. J., & Baguley, B. C. (2008). The role of topoisomerases and RNA transcription in the action of the antitumour benzonaphthyridine derivative SN 28049. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 62 (5), 753-762. 10.1007/s00280-007-0660-z
URL: http://hdl.handle.net/2292/17456
Other University of Auckland co-authors: Bruce Baguley
Contact details
- +64 9 923 6092
- +64.9.923.6092
- g.finlay@auckland.ac.nz
- gfin010@aucklanduni.ac.nz
Primary office location
M&HS BUILDING 504 - Bldg 504
Level 0, Room 018
85 PARK RD
GRAFTON
AUCKLAND 1023
New Zealand